Gerald D. Cagle Ph.D., has been appointed senior advisor and head of business development at GrayBug LLC. “GrayBug is at the forefront of innovative drug delivery strategies for ocular diseases and has the potential to significantly advance the ophthalmic industry with its unique sustained release technology,” said Dr. Cagle. “I am very excited to be joining the Graybug team and look forward to being involved in the progression of their novel drug delivery technology to market.” Dr. C...